Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Natera Inc
(NQ:
NTRA
)
118.26
+2.01 (+1.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Natera Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
May 09, 2024
Via
Benzinga
How Is The Market Feeling About Natera?
May 09, 2024
Via
Benzinga
Looking Into Natera's Recent Short Interest
April 23, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Natera
April 05, 2024
Via
Benzinga
Looking Into Natera's Recent Short Interest
April 05, 2024
Via
Benzinga
Disney, Natera, Chubb And A Major Tech Stock On CNBC's 'Final Trades'
March 12, 2024
On CNBC’s "Halftime Report Final Trades," Amy Raskin of Chevy Chase Trust said Natera, Inc.
Via
Benzinga
Recap: Natera Q4 Earnings
February 28, 2024
Via
Benzinga
Earnings Preview For Natera
February 27, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Natera Through 9 Analysts
February 20, 2024
Via
Benzinga
There are signs that NASDAQ:NTRA may be ready to breakout.
February 16, 2024
NATERA INC (NASDAQ:NTRA) has a good technical rating of 10 out of 10 and could possibly break out.
Via
Chartmill
9 Health Care Stocks Whale Activity In Today's Session
March 08, 2024
Via
Benzinga
Agilent Technologies Stock Getting Closer To Key Technical Benchmark
March 05, 2024
Agilent Technologies stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 65 to 71.
Via
Investor's Business Daily
Wall Street Takes A Breather As Inflation Stays Tamed, AMD Hits Record Highs, Apple Struggles: What's Driving Markets Thursday?
February 29, 2024
Wall Street exhaled a sigh of relief as the Federal Reserve’s favored gauge of inflation cooled as anticipated in January, quelling fears that an unexpected rise in the Consumer Price Index (CPI) might...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Expert Ratings For Natera
January 17, 2024
Via
Benzinga
The Analyst Landscape: 8 Takes On Natera
December 29, 2023
Via
Benzinga
The Latest Analyst Ratings for Natera
December 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 28, 2024
Via
Benzinga
Earnings Scheduled For February 28, 2024
February 28, 2024
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.
Via
Benzinga
Cathie Wood's Ark Invest Sheds $9.3M Worth Of Coinbase Shares Amid Bitcoin Rally — Robinhood Stock Also Sold
February 27, 2024
On Tuesday, Cathie Wood-led Ark Invest adjusted its portfolio, making significant trades.
Via
Benzinga
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
February 06, 2024
These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry.
Via
InvestorPlace
NVTA Stock: Invitae Plunges 78% on the Brink of Bankruptcy
February 06, 2024
NVTA stock tumbled yesterday amid a report that the firm could declare bankruptcy soon. The shares were halted for news pending.
Via
InvestorPlace
Topics
Bankruptcy
Exposures
Financial
Legal
SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy
February 05, 2024
Invitae's financial challenges as it grapples with a $1.5 billion debt burden. Explore the company's strategic options amidst potential bankruptcy, asset shedding, and cost-cutting measures.
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Pinterest, Checkpoint Therapeutics And 2 Other Stocks Insiders Are Selling
February 05, 2024
The Nasdaq 100 closed higher by around 300 points on Friday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle
January 17, 2024
The company must pay $57 million in damages, but that's far less than expected.
Via
Investor's Business Daily
Topics
Intellectual Property
Exposures
Intellectual Property
Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket
January 17, 2024
Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market...
Via
Benzinga
Progress Software Posts Strong Q4 Results, Joins Impinj, REGENXBIO And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
January 17, 2024
U.S. stock futures were lower this morning, with the Dow Jones futures falling more than 100 points on Wednesday. Shares of Progress Software Corporation (NASDAQ: PRGS) rose in pre-market trading as...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bull of the Day - NeoGenomics
January 12, 2024
But in late December, shares took a big hit on patent litigation with competitor Natera. Let's review the primary commercial business of NEO and then that will help put the legal news into context.
Via
Talk Markets
Topics
Intellectual Property
Exposures
Intellectual Property
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 29, 2023
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.
Via
Benzinga
Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday
December 29, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
US Court Prohibits NeoGenomics To Sell Type Of Diagnostic Kits To Detect Smaller Number Of Cancer Cells, Favoring Natera In Lawsuit
December 28, 2023
Shares of NeoGenomics Inc (NASDAQ: NEO) fell Thursday after the company received a preliminary injunction from a North Carolina district court, which prohibits the company from
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.